Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people. | Cell Rep Med | 2022 | 36075216 | PubTator, text mining | PubMed |
| Combined heterozygosity of FLT3 ITD, TET2, and DNMT3A results in aggressive leukemia. | JCI Insight | 2022 | 36073548 | PubTator, text mining | PubMed |
| Strategies to induce natural killer cell tolerance in xenotransplantation. | Front Immunol | 2022 | 36072599 | PubTator, text mining | PubMed |
| Mutations in BCOR, a co-repressor of CRX/OTX2, are associated with early-onset retinal degeneration. | Sci Adv | 2022 | 36070393 | PubTator, text mining | PubMed |
| Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia. | Stem Cell Res Ther | 2022 | 36068595 | PubTator, text mining | PubMed |
| Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures. | J Immunol Res | 2022 | 36065454 | PubTator, text mining | PubMed |
| Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities. | Front Mol Biosci | 2022 | 36060249 | PubTator, text mining | PubMed |
| Exploring the pathogenesis of diabetic kidney disease by microarray data analysis. | Front Pharmacol | 2022 | 36059966 | PubTator, text mining | PubMed |
| Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48. | J Transl Med | 2022 | 36058936 | PubTator, text mining | PubMed |
| Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM. | EBioMedicine | 2022 | 36054938 | PubTator, text mining | PubMed |
| Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma. | Front Genet | 2022 | 36051690 | PubTator, text mining | PubMed |
| KDELR3 Is a Prognostic Biomarker Related to the Immune Infiltration and Chemoresistance of Anticancer Drugs in Uveal Melanoma. | Dis Markers | 2022 | 36046379 | PubTator, text mining | PubMed |
| Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies. | Front Immunol | 2022 | 36045670 | PubTator, text mining | PubMed |
| WD repeat domain 6 as a novelty prognostic biomarker correlates with immune infiltration in lung cancer: A preliminary study. | Immun Inflamm Dis | 2022 | 36039642 | PubTator, text mining | PubMed |
| An Immune-Related lncRNA Pairing Model for Predicting the Prognosis and Immune-Infiltrating Cell Condition in Human Ovarian Cancer. | Biomed Res Int | 2022 | 36033566 | PubTator, text mining | PubMed |
| A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma. | Front Oncol | 2022 | 36033510 | PubTator, text mining | PubMed |
| HIV-1 induction of tolerogenic dendritic cells is mediated by cellular interaction with suppressive T cells. | Front Immunol | 2022 | 36032117 | PubTator, text mining | PubMed |
| Identification of prognostic gene expression signatures based on the tumor microenvironment characterization of gastric cancer. | Front Immunol | 2022 | 36032070 | PubTator, text mining | PubMed |
| ASPN Is a Potential Biomarker and Associated with Immune Infiltration in Endometriosis. | Genes (Basel) | 2022 | 36011263 | PubTator, text mining | PubMed |
| Novel Necroptosis-Related Gene Signature for Predicting Early Diagnosis and Prognosis and Immunotherapy of Gastric Cancer. | Cancers (Basel) | 2022 | 36010886 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=40